Independent Technology Assessment — Due Diligence Report

QuantumCore Materials Inc. (Private) | Advanced Materials / Energy Storage
STRONG INVEST
Assessed Fair Value: $180–220M post-money | Current Pre-B Valuation: $45M | Upside: 4–5x at Series C/D

Report Details

Report Date: March 26, 2026
Lead Analyst: Dr. Victoria Chen — Partner, Deep Tech Practice
Technical Reviewer: David Nakamura — Senior Associate, Materials Science
Report Type: Independent Technology Due Diligence
Engagement: Commissioned by prospective Series B co-investors
Recommendation: STRONG INVEST
Risk Rating: Moderate-High (typical for Series B deep tech)

Executive Summary

QuantumCore Materials represents a compelling deep tech investment opportunity in the solid-state battery space. The company's patent-pending QCMatrix solid-electrolyte technology addresses the critical dendrite suppression problem that has stalled commercialization across the industry. Our independent assessment — including a site visit to the company's Austin lab, review of internal test data, and consultation with three external materials science experts — indicates the technology is genuine and potentially best-in-class among pre-commercial solid-state approaches.

At the reported $45M pre-money Series B valuation, we believe the company is significantly undervalued relative to its technology quality, IP position, and the strategic interest it has attracted. Our fair value assessment of $180–220M is based on comparable transactions, technology benchmarking, and probability-weighted licensing scenarios.

Technical Assessment

We engaged Dr. Robert Keller, Professor of Materials Science at MIT, and Dr. Lisa Yamamoto, formerly head of solid-state R&D at Samsung SDI, to conduct independent reviews of QuantumCore's technical claims. Both were provided access to raw test data under NDA. Key findings:

Dr. Keller's written assessment: "The claims in QuantumCore's provisional patent application are scientifically plausible and, if validated at scale, would represent a meaningful advancement over the current state of the art. The roll-to-roll manufacturing approach is particularly noteworthy for its commercial practicality."

Dr. Yamamoto's written assessment: "I was initially skeptical of the conductivity claims, but the raw data I reviewed is internally consistent and shows clear reproducibility across multiple batches. I'd rate the probability of these results holding up in independent testing at around 70–75%."

Lab Visit Summary

Our team visited QuantumCore's Austin facility on March 14, 2026. Observations:

Valuation Analysis

MethodImplied ValuationWeight
Comparable transactions (Series B deep tech battery startups 2024-2026)$150–200M35%
Technology benchmarking vs. QuantumScape/Solid Power at equivalent stage$200–280M30%
Probability-weighted licensing DCF (12% discount rate, 5-yr horizon)$160–210M35%
Blended Fair Value: $180–220M post-money

Key Catalysts (Next 12 Months)

Competitive Landscape

CompanyStageLast ValuationBest Published Conductivity
QuantumScape (QS)Public$4.8B mkt cap~2.5 mS/cm (prototype cells)
Solid Power (SLDP)Public$680M mkt cap~1.5 mS/cm (A-sample)
Factorial EnergyPrivate, Series D$3.3B~2.0 mS/cm (reported)
SES AI (SES)Public$320M mkt capHybrid electrolyte, n/a
QuantumCore MaterialsPrivate, Series B$45M pre-B4.2 mS/cm (internal data)

If QuantumCore's conductivity results are confirmed by Argonne, the company would hold the best-in-class performance benchmark in the solid-state battery startup space. At $45M pre-money, the valuation discount to peers is extreme — even with the appropriate risk premium for earlier stage and private status.

Risk Factors

Important Disclosures: This report was commissioned and paid for by a consortium of prospective Series B investors in QuantumCore Materials. Meridian Ventures and its partners may co-invest in the Series B round. This assessment is based on information provided by the company and our independent verification efforts; however, we cannot guarantee the accuracy of all claims. This is not investment advice. Private company investments involve substantial risk of total loss. Accredited investors only.